Leading Change in Eye Health: A Conversation with Jason Menzo (FFB)

In this episode, we sit down with Jason Menzo, CEO of the Foundation Fighting Blindness, to discuss his unique journey from the pharmaceutical industry to leading one of the world’s most impactful organizations in eye health. Jason shares insights on his career transition into the nonprofit sector and his commitment to advancing the Foundation’s mission. We explore groundbreaking initiatives like My Retina Tracker, a resource bridging patients to clinical trials, and dive into the Foundation’s bold vision for future treatments, including the potential of eye transplants. Plus, hear how the Foundation is fueling innovation by investing in promising small eye care companies and funding research to combat inherited retinal diseases.


About the guest:

Jason Menzo is the CEO for the Foundation Fighting Blindness, the world’s leading organization advancing treatments and cures of blinding retinal degenerative diseases. The Foundation has raised nearly $1 billion since its inception and is currently funding more than 90 research projects globally.

Jason also serves on the management team for the Retinal Degeneration Fund (RD Fund), the venture arm of the Foundation. The RD Fund has over $100 million under management and has achieved dozens of significant clinical milestones in its first five years.

Prior to joining the Foundation, Jason was a co-founder and Business Unit Head of Sun Ophthalmics. In this role, he built and led the commercial team, launching the business into the well-known entity it is today. He was a co-founder of the US business for Nicox SA, where he led the commercial launches of several ophthalmic brands and helped the business successfully exit by acquisition (Valeant Pharmaceuticals, 2014). He has previously held positions of increasing responsibility with Bausch + Lomb, Inspire Pharmaceuticals, and Bayer Healthcare.

Jason also serves on the Board of Directors for Retina International, the leading global umbrella organization for patient-led charities and foundations. He has also served as a member for the Global Council of Advisors and Advocates for Sightlife, a global non-profit seeking to end corneal blindness.

Leave a Reply

Your email address will not be published. Required fields are marked *

*